Solliciteer als één van de eersten - R&D development areas include novel targets in neurologic disorders, gastroenterology, oncology, diabetes, hematology, metabolic disorders, immunologic disorders, pulmonary hypertension and reproductive medicine. The PLD team is at the forefront of innovation, developing Parenteral and Liquid drug product formulations and processes across our R&D Synthetics portfolio (small molecules, peptides, oligonucleotides, drug conjugates), from late discovery through preclinical and clinical development, and into commercialization. We explore a wide range of administration routes — oral, IV, IT, IM, SC, intra-organ, intra-tumoral, transmucosal, transdermal, nasal, ophthalmic — supporting both systemic drug delivery and local or targeted drug delivery approaches to address un
plus